Product Name :
Anti-SARS-CoV-2 Spike(Adintrevimab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
SARS-CoV-2 Spike
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-SARS-CoV-2 Spike(Adintrevimab Biosimilar) Antibody is a biosimilar antibody directed against SARS-CoV-2 Spike.{{216503-57-0} MedChemExpress|{216503-57-0} Technical Information|{216503-57-0} In Vivo|{216503-57-0} custom synthesis} | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: SARS-CoV-2 Spike | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-SARS-CoV-2 Spike(Adintrevimab Biosimilar) Antibody is a biosimilar antibody directed against SARS-CoV-2 Spike.
Immunogen:
Host :
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{259793-96-9} web|{259793-96-9} Technical Information|{259793-96-9} In Vitro|{259793-96-9} custom synthesis} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.PMID:30020711 The actual dilution used must be determined empirically.
